Drug Shortage Report for LIPIDIL SUPRA
| Report ID | 166046 |
| Drug Identification Number | 02241602 |
| Brand name | LIPIDIL SUPRA |
| Common or Proper name | LIPIDIL SUPRA |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | FENOFIBRATE |
| Strength(s) | 160MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 3x10 |
| ATC code | C10AB |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-10-05 |
| Actual start date | |
| Estimated end date | 2022-10-11 |
| Actual end date | 2022-08-15 |
| Shortage status | Avoided shortage |
| Updated date | 2022-08-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-08-15 | French | Compare |
| v3 | 2022-08-15 | English | Compare |
| v2 | 2022-08-03 | French | Compare |
| v1 | 2022-08-03 | English | Compare |
Showing 1 to 4 of 4